Insider Shareholders with Direct Ownership of T Scan Therapeutics, Inc. (TCRX)
This section provides a comprehensive overview of the insiders with direct ownership of T Scan Therapeutics, Inc. (TCRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
TScan Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
David P Southwell
Chief Executive Officer |
84,670 | 0 | 171,569 $706,864 | 3 |
May 18, 2022
Added 5.51%
|
| 100,286 | 0 | 67,027 $276,151 | 4 |
Dec 19, 2023
Added 0.47%
|
|
|
Gavin Mac Beath
Chief Executive Officer |
5,000 | 0 | 49,767 $205,040 | 2 |
Sep 21, 2021
Added 0.11%
|
| 20,000 | 0 | 45,000 $185,400 | 4 |
Sep 23, 2024
Added 10.0%
|
|
|
Brian M. Silver
Chief Financial Officer |
32,885 | 0 | 32,885 $135,486 | 6 |
Dec 28, 2022
Added 8.76%
|
| 161,902 | 164,686 | 4,716 $19,429 | 3 |
Aug 23, 2024
Reduced 97.22%
|
|
|
William Desmarais
Chief Business Officer |
2,500 | 0 | 2,500 $10,300 | 1 |
Aug 27, 2021
Added 50.0%
|